DANVERS, MASS. – Beckman Coulter, Inc. has obtained a CLIA Certificate of Registration, along with Massachusetts State Licensure, allowing Beckman Coulter Genomics to begin accepting clinical samples for genetic sequencing – the most technically complex CLIA category – and to provide those results to physicians for their use in treating, diagnosing and preventing disease in […]
SOUTH SAN FRANCISCO, Calif. – Fluidigm Corporation (NASDAQ:FLDM) today announced that it can now offer unrestricted sales of its digital PCR and other advanced technology to customers interested in pursuing research and product development into the prenatal health and non-invasive prenatal diagnostics fields, as well as other fields. This enhanced freedom to operate comes as […]
Dublin (Ireland), – The DiaSorin Group announces that it has concluded with the NorDiag Group, with effect as from May 4, 2012, a contract for the acquisition of its business line, technology, patents and know how related to the extraction of nucleic acids used for molecular diagnostic applications. NorDiag ASA, holding company of the NorDiag […]
HILDEN, Germany, and Germantown, Maryland, USA — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the acquisition of AmniSure International LLC, a privately owned Boston company that markets the AmniSure® assay for determining whether a pregnant woman is suffering rupture of fetal membranes (ROM), a condition in which fluid leaks from the amniotic […]
Germantown, Maryland, and Hilden, Germany, – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has joined the Point-of-Care Diagnostics (POC Dx) Initiative led by the Bill & Melinda Gates Foundation and Grand Challenges Canada to create a new molecular diagnostics platform to serve resource-poor regions of the world. QIAGEN has already started […]
Germantown, MD, and Hilden, Germany,— QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that Cardinal Health (NYSE: CAH) has extended its portfolio of laboratory offerings to select U.S. hospitals to include QIAGEN automated laboratory systems and test kits for molecular diagnostics. Cardinal Health, a leading health care services company, will distribute QIAGEN’s molecular […]
Nanosphere, Inc. (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today announced that it entered into a marketing and distribution agreement with Thermo Fisher Scientific Inc. for markets in Germany, Austria and France. Thermo Fisher, the world leader in serving science, has a broad portfolio of products for microbiological applications. […]
Constance, Germany,– LifeCodexx AG today announced the successful completion of the clinical validation study of its noninvasive test method for the detection of fetal trisomy 21 from maternal blood using Next Generation sequencing. First results from the prospective blinded multi-center study demonstrate highest clinical accuracy for the planned commercial PraenaTest® test design based on Cell-Free […]
AUSTIN, Texas,– Luminex Corporation (NASDAQ: LMNX) announced today that it has received CE marking of both the xMAP NeoPlex4 Assay and NeoPlex® System. This unique system revolutionizes the way newborn screening is performed, providing four assays from one blood spot punch, reducing sample requirements and improving laboratory efficiency. Millions of infants have blood drawn from […]
SALT LAKE CITY,– Idaho Technology, Inc., a privately held clinical diagnostics company dedicated to providing the world’s fastest, highest-quality instruments for pathogen identification and DNA analysis, today announced the presentation of several posters highlighting the Company’s diagnostic FilmArray® Respiratory Panel (FilmArray RP), a user-friendly multiplex pathogen detection system that simultaneously tests for 15 different pathogens, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
